BMO Capital Reiterates Outperform Rating on AMN Healthcare (AMN)
Tweet Send to a Friend
BMO Capital analyst Jeffrey Silber reiterated an Outperform rating and $71.00 price target on AMN Healthcare (NYSE: AMN).The analyst commented ...
This is a premium only article. To continue reading this and other premium stock market news articles please sign-in or upgrade to StreetInsider.com Premium below (Free Trial) LEARN MORE
This is a premium only article. To continue reading this and other premium stock market news articles please sign-in or upgrade to StreetInsider.com Premium below (Free Trial) LEARN MORE


